Sarepta Therapeutics Inc (SRPT)

Debt-to-capital ratio

Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019
Long-term debt US$ in thousands 1,133,660 1,132,520 1,236,760 1,235,520 1,234,280 1,544,290 1,542,770 1,100,870 1,098,850 1,096,880 1,094,910 1,092,980 1,091,110 992,493 700,470 694,156 687,953 681,900 436,421 431,040
Total stockholders’ equity US$ in thousands 961,192 859,337 764,357 741,411 712,749 384,950 430,840 726,457 856,886 928,009 469,528 485,108 535,445 761,759 892,047 1,042,870 1,144,830 818,187 995,204 1,099,170
Debt-to-capital ratio 0.54 0.57 0.62 0.62 0.63 0.80 0.78 0.60 0.56 0.54 0.70 0.69 0.67 0.57 0.44 0.40 0.38 0.45 0.30 0.28

March 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $1,133,660K ÷ ($1,133,660K + $961,192K)
= 0.54

The debt-to-capital ratio of Sarepta Therapeutics Inc has shown fluctuations over the past few quarters. In the most recent quarter ending March 31, 2024, the ratio stood at 0.54, indicating that 54% of the company's capital structure was funded by debt. This represents a slight decrease from the ratio of 0.57 at the end of December 31, 2023.

Overall, the trend in the debt-to-capital ratio has been somewhat volatile, with fluctuations observed between 0.28 and 0.80 over the past five years. The ratio peaked at 0.80 in December 31, 2022, and has since shown a declining trend, reaching its lowest point at 0.28 in September 30, 2019.

A higher debt-to-capital ratio indicates a higher level of financial risk as the company relies more heavily on debt to fund its operations. Conversely, a lower ratio suggests a more conservative financial structure with a higher proportion of equity financing.

It is important for stakeholders to closely monitor changes in the debt-to-capital ratio to assess the company's financial health, risk profile, and ability to service its debt obligations.